Elanco Animal Health, Inc. (ELAN)
24.58
+0.48
(+1.99%)
USD |
NYSE |
Nov 03, 16:00
24.58
0.00 (0.00%)
After-Hours: 17:51
Elanco Animal Health Net Income (Quarterly) : 54.00M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 54.00M |
| March 31, 2026 | 57.00M |
| December 31, 2025 | -276.00M |
| September 30, 2025 | -34.00M |
| June 30, 2025 | 11.00M |
| March 31, 2025 | 67.00M |
| December 31, 2024 | -8.00M |
| September 30, 2024 | 364.00M |
| June 30, 2024 | -50.00M |
| March 31, 2024 | 32.00M |
| December 31, 2023 | -141.00M |
| September 30, 2023 | -1.096B |
| June 30, 2023 | -97.00M |
| March 31, 2023 | 103.00M |
| December 31, 2022 | -54.00M |
| September 30, 2022 | -65.00M |
| June 30, 2022 | -10.00M |
| Date | Value |
|---|---|
| March 31, 2022 | 51.00M |
| December 31, 2021 | -104.00M |
| September 30, 2021 | -104.00M |
| June 30, 2021 | -210.00M |
| March 31, 2021 | -61.00M |
| December 31, 2020 | -322.80M |
| September 30, 2020 | -135.00M |
| June 30, 2020 | -53.20M |
| March 31, 2020 | -49.10M |
| December 31, 2019 | -9.50M |
| September 30, 2019 | 10.00M |
| June 30, 2019 | 35.90M |
| March 31, 2019 | 31.50M |
| December 31, 2018 | 16.40M |
| September 30, 2018 | 60.20M |
| June 30, 2018 | -62.80M |
| March 31, 2018 | 72.70M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Eli Lilly & Co. | 6.451B |
| ANI Pharmaceuticals, Inc. | 23.00M |
| Zoetis, Inc. | 691.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.368B |
| Total Expenses (Quarterly) | 1.314B |
| EPS Diluted (Quarterly) | 0.1067 |
| Enterprise Value | 15.43B |
| Gross Profit Margin (Quarterly) | 48.17% |
| Profit Margin (Quarterly) | 3.95% |
| Earnings Yield | -1.65% |
| Operating Earnings Yield | 2.70% |
| Normalized Earnings Yield | -0.3511 |